Docs told to avoid 1 flu shot brand for small kids

Aug 05, 2010 By MIKE STOBBE , AP Medical Writer

(AP) -- A government panel is recommending doctors steer clear of giving one brand of flu vaccine to young children this year because of problems with it in Australia and New Zealand.

At issue is a flu shot made by CSL Biotherapies, an Australian company. There was an unexplained higher rate of fevers and seizures in children who got the vaccine this spring in those countries.

The Australian company is making vaccine for Americans this fall, but only a small portion of the 170 million doses.

On Thursday, the Advisory Committee on Immunization Practices said doctors should avoid using the Australian in children under 8, especially in those under 5.

U.S. officials say they have not seen similar problems with other vaccines.

Explore further: FDA OKs Cubist antibiotic for serious infections

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Flu season: How many shots?

Aug 30, 2009

(AP) -- Doctors don't know yet if it will take one dose or two of vaccine to protect against the new swine flu. Add that to vaccine for the regular winter flu, and it could be a multishot season for a lot of people - or ...

Possible seasonal shot seen for bird flu

May 04, 2006

A seasonal flu shot against a possible bird flu pandemic is reported to be under consideration by U.S. public health officials at a Singapore conference.

FDA approves new swine flu vaccine

Sep 15, 2009

(AP) -- The Food and Drug Administration approved the new swine flu vaccine Tuesday, a long-anticipated step as the government works to get vaccinations under way next month. Health and Human Services Secretary ...

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.